Condition: Hypotension Symptomatic · Parkinson's Disease · Orthostatic Hypotension, Dysautonomic · Sponsor: Ecole Polytechnique Fédérale de Lausanne
The PD-HemON study aims to evaluate the safety and preliminary efficacy of ARC-IM Therapy (Epidural Electrical Stimulation) to support hemodynamic management in people with typical and atypical Parkinson's Disease, who suffer from orthostatic hypotension.
This description comes directly from the study's public registry record.
Gregoire Courtine, PhD · +41 21 69 30762 · gregoire.courtine@epfl.ch
Always discuss trial participation with your own doctor first.
| CHUV | Lausanne, Canton of Vaud, Switzerland | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06920134